Also trades as: 0809.HK (HKSE) · $vol 0M
GBCMY OTC
Global Bio-chem Technology Group Company Limited
1W: +0.0%
1M: +0.0%
3M: +0.0%
YTD: -15.0%
1Y: -15.0%
3Y: -55.0%
$4.14
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
$76M
+250.7% ▲
5Y CAGR: -18.5%
Capital Expenditures
$0
+100.0% ▲
Free Cash Flow
$76M
+180.7% ▲
5Y CAGR: -13.8%
Dividends Paid
$0
+0.0% ▲
Buybacks
$3M
+0.0% ▲
Net Change in Cash
-$3M
-106.0% ▼
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$2.4B | -$409M | -$1.6B | $4.2B | $770M |
| Depreciation & Amort. | $457M | $403M | $331M | $305M | $229M |
| Stock-Based Comp. | $0 | $0 | $0 | $0 | $0 |
| Change in Working Capital | $566M | $38M | $414M | $292M | -$351M |
| Other Non-Cash Items | $1.4B | -$506M | $741M | -$4.8B | -$571M |
| Operating Cash Flow | -$26M | -$475M | -$88M | -$50M | $76M |
| — Investing Activities — | |||||
| Capital Expenditures | -$17M | -$26M | -$6M | -$44M | $0 |
| Acquisitions (Net) | -$1K | $418M | $6M | $29M | -$535K |
| Investment Purchases | $0 | $0 | $0 | $0 | $0 |
| Investment Sales | $0 | $0 | $0 | $0 | $0 |
| Other Investing | $137M | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $120M | $393M | -$413K | -$14M | -$535K |
| — Financing Activities — | |||||
| Net Debt Issuance | -$59M | $13M | $124M | $168M | -$1.7B |
| Stock Repurchased | $0 | $0 | $0 | $0 | -$3M |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | -$99M | -$61M | -$14M | -$55M | $1.7B |
| Financing Cash Flow | -$26M | -$49M | $110M | $113M | -$76M |
| Net Change in Cash | $74M | -$132M | $20M | $46M | -$3M |
| Cash End of Period | $153M | $22M | $42M | $88M | $85M |
| Free Cash Flow | -$43M | -$501M | -$94M | -$94M | $76M |